We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

71 hedge funds and large institutions have $53.8M invested in T2 Biosystems, Inc in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

15% less funds holding

Funds holding: 8471 (-13)

19% less capital invested

Capital invested by funds: $66.2M → $53.8M (-$12.3M)

45% less call options, than puts

Call options by funds: $236K | Put options by funds: $431K

57% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 21

Holders
71
Holders Change
-13
Holders Change %
-15.48%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
22
Reduced
17
Closed
21
Calls
$236K
Puts
$431K
Net Calls
-$195K
Net Calls Change
-$94K
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$11.3M +$51K +3 +0.3%
SM
2
Senvest Management
New York
$6.73M -$936K -55 -10%
BlackRock
3
BlackRock
New York
$6.52M +$1.45M +85 +21%
PVMCV
4
Polaris Venture Management Co V
Massachusetts
$4.84M
Morgan Stanley
5
Morgan Stanley
New York
$4.4M -$442K -26 -7%
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.04M +$1.21M +71 +44%
AAP
7
Ardsley Advisory Partners
Connecticut
$2.17M +$391K +23 +16%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$1.58M +$953K +56 +88%
Allianz Asset Management
9
Allianz Asset Management
Germany
$1.28M
State Street
10
State Street
Massachusetts
$1.27M +$85.1K +5 +5%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.16M +$221K +13 +17%
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$1.05M
Northern Trust
13
Northern Trust
Illinois
$970K +$17K +1 +1%
BRC
14
Bell Rock Capital
Delaware
$897K +$68.1K +4 +6%
Fuller & Thaler Asset Management
15
Fuller & Thaler Asset Management
California
$831K -$221K -13 -17%
EIM
16
Essex Investment Management
Massachusetts
$526K -$493K -29 -42%
BCM
17
Bridgeway Capital Management
Texas
$395K
GS
18
Gagnon Securities
New York
$392K +$289K +17 +131%
SIA
19
Sit Investment Associates
Minnesota
$374K
Bank of New York Mellon
20
Bank of New York Mellon
New York
$264K -$17K -1 -5%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$232K -$238K -14 -44%
FAM
22
Fred Alger Management
New York
$224K +$34K +2 +13%
LCS
23
Levin Capital Strategies
New York
$197K -$85.1K -5 -25%
Wells Fargo
24
Wells Fargo
California
$183K
Charles Schwab
25
Charles Schwab
California
$181K

TTOO Hedge Fund Activity: Q1 2019 in Review

71 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2019, worth a combined $53.8M — down 19% from $66.2M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of TTOO and 9 opened new positions — a net loss of 12 holders — while 17 trimmed existing stakes and 22 added.

The largest buyer was BlackRock, adding an estimated $1.45M. The largest seller was Tiger Management, exiting entirely with an estimated $2.47M sold.

  • 71 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2019, down from 84 in Q4 2018.
  • Funds reported $53.8M of T2 Biosystems, Inc stock for Q1 2019, down 19% quarter-over-quarter.
  • 9 funds opened new T2 Biosystems, Inc positions in Q1 2019 and 21 closed out, a net change of -12 holders.
  • The largest T2 Biosystems, Inc buyer in Q1 2019 was BlackRock, an estimated $1.45M added.
  • The largest T2 Biosystems, Inc seller in Q1 2019 was Tiger Management, an estimated $2.47M sold.

Based on aggregated 13F filings for Q1 2019.